Author:
A. Sathyaraj ,R. Balaji ,C. Cibi ,T. Deepak
Abstract
Gold nanoparticles (GNPs) have been extensively used in various applications in pharmaceuticals applications. Due to their unique characteristics such as tunable surface properties as well as surface plasmon resonance (SPR), GNPs have garnered attention in various applications exclusively in therapy and diagnostics. Gold nanoparticles (GNPs) are one of many NPs that have long been the focus of research. Due to their flexibility in synthesis and functionalization, GNPs have been profoundly used in treatments and diagnostic purpose. This article discusses and highlights therapeutic characteristics of GNPs that have been exploited in biomedical applications in recent years to improve biomedical research in various biomedical field such as nuclear medicine, molecular imaging and contrast agent, vaccine development, medical implant, diagnostics, biosensing, and lab-on-chip applications. At the forefront of modern therapeutic technology, GNPs based cancer treatment, antiviral agents and etc., have great potential which is also highlighted briefly in this article
Reference22 articles.
1. Chen F, Si P, de la Zerda A, Jokerst JV, Myung D. Gold nanoparticles: promising biomaterials for osteogenic/adipogenic regulation in bone repair. J Mater Chem B. 2023.
2. Zhang Yangheng, Wang P, Wang Y, Li J, Icon D, Icon RC et al. Gold nanoparticles promote the bone regeneration of periodontal ligament stem cell sheets through activation of autophagy. Int J Nanomedicine. 2023.
3. Gupta Arti, Pandey S, Yadav JS. A review on recent trends in green synthesis of gold nanoparticles for tuberculosis. Adv Pharm Bull. 2021;11(1):10-27. doi: 10.34172/apb.2021.002, PMID 33747849.
4. Sivanesan S, Rajeshkumar S. Gold nanoparticles in diagnosis and treatment of Alzheimer’s disease. Nanobiotechnology Neurodegener Dis. 2019.
5. Khan Suliman, Anwarul Hasan F Attar, Majid Sharifi, Rabeea Siddique. Fatima Mraiche and Mojtaba Falahati. Gold nanoparticle-based platforms for diagnosis and treatment of myocardial infarction. ACS Publications. 2020.